These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20640982)

  • 41. An update on anal cancer diagnosis and treatment.
    Salmo E; Haboubi N
    Pol Przegl Chir; 2011 Feb; 83(2):108-16. PubMed ID: 22166290
    [No Abstract]   [Full Text] [Related]  

  • 42. Images in HIV/AIDS. The changing face of anal cancer.
    Romassi M; Nagle D
    AIDS Read; 2008 Apr; 18(4):185-7. PubMed ID: 18472440
    [No Abstract]   [Full Text] [Related]  

  • 43. Keratoacanthoma in the differential diagnosis of anal carcinoma: difficult diagnosis, easy therapy. Report of three cases.
    Küppers F; Jongen J; Bock JU; Rabenhorst G
    Dis Colon Rectum; 2000 Mar; 43(3):427-9. PubMed ID: 10733129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome?
    Goh V; Gollub FK; Liaw J; Wellsted D; Przybytniak I; Padhani AR; Glynne-Jones R
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):715-21. PubMed ID: 20171812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathology of anal cancer.
    Morson BC; Pang LS
    Proc R Soc Med; 1968 Jun; 61(6):623-4. PubMed ID: 5662220
    [No Abstract]   [Full Text] [Related]  

  • 46. Lugol chromoendoscopy: might it be useful to improve detection of early dysplastic or neoplastic lesions of the anal canal in high-risk patients?
    Antonietti M; Lecleire S; Ben Soussan E; Paillot B; Di Fiore F; Lerebours E; Ducrotté P
    Endoscopy; 2008 Sep; 40 Suppl 2():E47. PubMed ID: 18300204
    [No Abstract]   [Full Text] [Related]  

  • 47. [Anal carcinoma in Crohn disease].
    García Díaz E; Castro M; Romero Gómez M; Guerrero P; Romero A; Escribano L
    Gastroenterol Hepatol; 2000 Mar; 23(3):150-1. PubMed ID: 10804697
    [No Abstract]   [Full Text] [Related]  

  • 48. Guidelines for management of anal intraepithelial neoplasia.
    Scholefield JH; Harris D; Radcliffe A
    Colorectal Dis; 2011 Feb; 13 Suppl 1():3-10. PubMed ID: 21251167
    [No Abstract]   [Full Text] [Related]  

  • 49. Anal cancer masked by benign lesions.
    Matteucci P; Pittamiglio H; López-Susviela J
    Int Surg; 1983; 68(2):183-4. PubMed ID: 6885303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Squamous cell carcinoma of the canal anal].
    Guimarães AP; Matos D; Segreto R; Forones NM
    Arq Gastroenterol; 2001; 38(1):9-13. PubMed ID: 11582966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of the "squamous cell carcinoma antigen" as marker of epidermoid cancer of the anal canal].
    Fontana X; Lagrange JL; François E; Bourry J; Chauvel P; Sordage M; Lapalus F; Namer M
    Ann Gastroenterol Hepatol (Paris); 1991 Nov; 27(6):293-6. PubMed ID: 1772243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Prolapsing Pile Revealing Anal Squamous Cell Carcinoma.
    Daniel F; Trak-Smayra V; Ziade N
    Am J Gastroenterol; 2016 Apr; 111(4):454. PubMed ID: 27125703
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic problems in anal pathology.
    Longacre TA; Kong CS; Welton ML
    Adv Anat Pathol; 2008 Sep; 15(5):263-78. PubMed ID: 18724100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Our experience in carcinomas of anal canal and anus].
    Baldonedo Cernuda R; González Martínez J; Martínez Torres MD; Lana Gómez A
    Rev Esp Enferm Apar Dig; 1985 Feb; 67(2):171-6. PubMed ID: 3983453
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical aspects and diagnosis of the "anal and rectal carcinoma"].
    Dohrmann R
    Arch Dermatol Forsch; 1972; 244():377-82. PubMed ID: 4346245
    [No Abstract]   [Full Text] [Related]  

  • 56. [Ulcerated anal tumors. Freiburg gastroenterology discussions].
    Krüger HJ; Haag K; Glatt E; Hellerich U; Lausen M
    Med Klin (Munich); 1989 Jul; 84(7):344-6. PubMed ID: 2796863
    [No Abstract]   [Full Text] [Related]  

  • 57. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.
    Bilimoria KY; Bentrem DJ; Rock CE; Stewart AK; Ko CY; Halverson A
    Dis Colon Rectum; 2009 Apr; 52(4):624-31. PubMed ID: 19404066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients.
    Tramujas da Costa e Silva I; de Lima Ferreira LC; Santos Gimenez F; Gonçalves Guimarães RA; Botinelly Fujimoto L; Barbosa Cabral CR; Venturim Mozzer R; de Souza Atala L
    Ann Surg Oncol; 2008 May; 15(5):1470-5. PubMed ID: 18299937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of CD31 antigen expression in anal canal carcinoma.
    Indinnimeo M; Cicchini C; Stazi A; Limiti MR; Ghini C; Mingazzini PL; Vecchione A
    Hepatogastroenterology; 2001; 48(41):1355-8. PubMed ID: 11677963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Education and Imaging. Gastrointestinal: advanced untreated anal canal squamous cell carcinoma.
    Garg PK; Jain BK
    J Gastroenterol Hepatol; 2013 Jun; 28(6):901. PubMed ID: 23692575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.